FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021929534> ?p ?o ?g. }

• W2021929534 endingPage "e29330" @default.
• W2021929534 startingPage "e29330" @default.
• W2021929534 abstract "Background Body weight and body composition are relevant to the outcomes of cancer and antineoplastic therapy. However, their role in Phase I clinical trial patients is unknown. Methods We reviewed symptom burden, body composition, and survival in 104 patients with advanced cancer referred to a Phase I oncology service. Symptom burden was analyzed using the MD Anderson Symptom Assessment Inventory(MDASI); body composition was evaluated utilizing computerized tomography(CT) images. A body mass index (BMI)≥25 kg/m2 was considered overweight. Sarcopenia, severe muscle depletion, was assessed using CT-based criteria. Results Most patients were overweight (n = 65, 63%); 53 patients were sarcopenic (51%), including 79% of patients with a BMI<25 kg/m2 and 34% of those with BMI≥25 kg/m2. Sarcopenic patients were older and less frequently African-American. Symptom burden did not differ among patients classified according to BMI and presence of sarcopenia. Median (95% confidence interval) survival (days) varied according to body composition: 215 (71–358) (BMI<25 kg/m2; sarcopenic), 271 (99–443) (BMI<25 kg/m2; non-sarcopenic), 484 (286–681) (BMI≥25 kg/m2; sarcopenic); 501 d (309–693) (BMI≥25 kg/m2; non-sarcopenic). Higher muscle index and gastrointestinal cancer diagnosis predicted longer survival in multivariate analysis after controlling for age, gender, performance status, and fat index. Conclusions Patients referred to a Phase I clinic had a high frequency of sarcopenia and a BMI≥25 kg/m2, independent of symptom burden. Body composition variables were predictive of clinically relevant survival differences, which is potentially important in developing Phase I studies." @default.
• W2021929534 created "2016-06-24" @default.
• W2021929534 creator A5004583668 @default.
• W2021929534 creator A5010704818 @default.
• W2021929534 creator A5026095888 @default.
• W2021929534 creator A5044200630 @default.
• W2021929534 creator A5053481267 @default.
• W2021929534 date "2012-01-03" @default.
• W2021929534 modified "2023-10-17" @default.
• W2021929534 title "Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service" @default.
• W2021929534 cites W1595744633 @default.
• W2021929534 cites W1854243381 @default.
• W2021929534 cites W1859428941 @default.
• W2021929534 cites W1896432851 @default.
• W2021929534 cites W1967645160 @default.
• W2021929534 cites W1972732808 @default.
• W2021929534 cites W1979521671 @default.
• W2021929534 cites W1980038286 @default.
• W2021929534 cites W1980498677 @default.
• W2021929534 cites W1996195782 @default.
• W2021929534 cites W1996437556 @default.
• W2021929534 cites W2002712062 @default.
• W2021929534 cites W2003064100 @default.
• W2021929534 cites W2004991633 @default.
• W2021929534 cites W2012034845 @default.
• W2021929534 cites W2020589362 @default.
• W2021929534 cites W2038725811 @default.
• W2021929534 cites W2045815176 @default.
• W2021929534 cites W2057482464 @default.
• W2021929534 cites W2061114783 @default.
• W2021929534 cites W2061366514 @default.
• W2021929534 cites W2067284974 @default.
• W2021929534 cites W2068008235 @default.
• W2021929534 cites W2075441909 @default.
• W2021929534 cites W2083697762 @default.
• W2021929534 cites W2096628118 @default.
• W2021929534 cites W2097022747 @default.
• W2021929534 cites W2101398993 @default.
• W2021929534 cites W2102335858 @default.
• W2021929534 cites W2104357394 @default.
• W2021929534 cites W2106342888 @default.
• W2021929534 cites W2107089530 @default.
• W2021929534 cites W2109364152 @default.
• W2021929534 cites W2112493932 @default.
• W2021929534 cites W2127424726 @default.
• W2021929534 cites W2132419409 @default.
• W2021929534 cites W2135951576 @default.
• W2021929534 cites W2142144836 @default.
• W2021929534 cites W2149626936 @default.
• W2021929534 cites W2150719741 @default.
• W2021929534 cites W2152963742 @default.
• W2021929534 cites W2158151049 @default.
• W2021929534 cites W2161349877 @default.
• W2021929534 cites W2161889485 @default.
• W2021929534 cites W2164956805 @default.
• W2021929534 cites W2248365950 @default.
• W2021929534 cites W2766032112 @default.
• W2021929534 doi "https://doi.org/10.1371/journal.pone.0029330" @default.
• W2021929534 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3250428" @default.
• W2021929534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22235285" @default.
• W2021929534 hasPublicationYear "2012" @default.
• W2021929534 type Work @default.
• W2021929534 sameAs 2021929534 @default.
• W2021929534 citedByCount "82" @default.
• W2021929534 countsByYear W20219295342012 @default.
• W2021929534 countsByYear W20219295342013 @default.
• W2021929534 countsByYear W20219295342014 @default.
• W2021929534 countsByYear W20219295342015 @default.
• W2021929534 countsByYear W20219295342016 @default.
• W2021929534 countsByYear W20219295342017 @default.
• W2021929534 countsByYear W20219295342018 @default.
• W2021929534 countsByYear W20219295342019 @default.
• W2021929534 countsByYear W20219295342020 @default.
• W2021929534 countsByYear W20219295342021 @default.
• W2021929534 countsByYear W20219295342022 @default.
• W2021929534 countsByYear W20219295342023 @default.
• W2021929534 crossrefType "journal-article" @default.
• W2021929534 hasAuthorship W2021929534A5004583668 @default.
• W2021929534 hasAuthorship W2021929534A5010704818 @default.
• W2021929534 hasAuthorship W2021929534A5026095888 @default.
• W2021929534 hasAuthorship W2021929534A5044200630 @default.
• W2021929534 hasAuthorship W2021929534A5053481267 @default.
• W2021929534 hasBestOaLocation W20219295341 @default.
• W2021929534 hasConcept C121608353 @default.
• W2021929534 hasConcept C126322002 @default.
• W2021929534 hasConcept C1862650 @default.
• W2021929534 hasConcept C2776214593 @default.
• W2021929534 hasConcept C2777319248 @default.
• W2021929534 hasConcept C2777328239 @default.
• W2021929534 hasConcept C2780221984 @default.
• W2021929534 hasConcept C2780586474 @default.
• W2021929534 hasConcept C44249647 @default.
• W2021929534 hasConcept C71924100 @default.
• W2021929534 hasConceptScore W2021929534C121608353 @default.
• W2021929534 hasConceptScore W2021929534C126322002 @default.
• W2021929534 hasConceptScore W2021929534C1862650 @default.
• W2021929534 hasConceptScore W2021929534C2776214593 @default.
• W2021929534 hasConceptScore W2021929534C2777319248 @default.

• next